Company / PP&E (Net)
Progyny PP&E (Net) History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$29.9M
FY2025
5-year range
$5.0M / $29.9M
FY2021-FY2025
Trend
+141.7%
vs FY2024
Sector context
#107 of 135
Health Care
What the data says
Progyny's pp&e (net) of $30M is lower than 79% of companies in the Health Care sector (FY2025). PP&E (Net) has increased for 7 consecutive years, from $776,000 in FY2018 to $30M in FY2025.
Based on SEC 10-K filings.
$30M in FY2025 with a 5-year CAGR of +54.5%.
Improved from $10M to $30M over the past 2 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- +52.9%
- 5-Year CAGR
- +54.5%
- 10-Year CAGR
- -
Sector benchmark
Bottom 21% in Health CareTop 79% of 135This company $29.9M Sector average $1.4B
▼
-97.8% below sector average
Key checks
Key Insights
- Progyny's pp&e (net) has grown for 7 consecutive years.
- 5-year CAGR of +54.5%, indicating consistent growth.
- In FY2025, pp&e (net) increased 141.7% year-over-year.
- Ranks #107 out of 135 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 3.62 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $29.9M | +141.7% |
| FY2024 | $12.4M | +21.2% |
| FY2023 | $10.2M | +22.0% |
| FY2022 | $8.4M | +66.5% |
| FY2021 | $5.0M | +47.9% |
| FY2020 | $3.4M | +10.3% |
| FY2019 | $3.1M | +297.3% |
| FY2018 | $776.0K | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026